The Ensign Group (ENSG)
NASDAQ:ENSG
Want to see ENSG full AI Analyst Report?
ENSG Stock Chart & Stats
$200.11
$0.93(0.71%)
At close: 4:00 PM EST
$200.11
$0.93(0.71%)
Day’s Range― - ―
52-Week Range$125.33 - $218.00
Previous CloseN/A
Volume60.10K
Average Volume (3M)324.62K
Market Cap
$11.10B
Enterprise Value$14.65B
Total Cash (Recent Filing)$572.39M
Total Debt (Recent Filing)$4.15B
Price to Earnings (P/E)29.0
Beta0.22
Next Earnings
Jul 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.14%
Share Statistics
EPS (TTM)N/A
Shares Outstanding58,413,970
10 Day Avg. Volume257,479
30 Day Avg. Volume324,620
Financial Highlights & Ratios
PEG Ratio2.06
Price to Book (P/B)4.47
Price to Sales (P/S)1.97
P/FCF Ratio26.93
Enterprise Value/Market Cap1.32
Enterprise Value/Revenue2.90
Enterprise Value/Gross Profit21.08
Enterprise Value/Ebitda25.80
Forecast
1Y Price Target
$222.33Price Target Upside11.11% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)7.52
Revenue Forecast (FY)$5.79B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue & Earnings GrowthMulti-year top-line and profit expansion demonstrates scalable core operations and durable demand for post-acute services. Consistent revenue and EPS growth indicates improving payer mix, referral traction and operational leverage that can sustain earnings over the next 2–6 months and beyond.
Robust Cash Generation & LiquidityStrong 2025 cash flow and >$1B total liquidity give the company durable financial flexibility to fund acquisitions, CapEx, dividends and working capital. Healthy cash conversion in 2025 reduces refinancing risk and supports strategic growth even if near-term earnings face headwinds.
High Clinical Quality And ExecutionSuperior clinical scores and above-market occupancy support durable referral flows, higher acuity and better payer mixes. Proven ability to integrate and improve operations (82 additions since 2024) signals repeatable execution that underpins sustainable margin and revenue expansion.
Bears Say
Elevated LeverageMaterial absolute debt and moderate leverage leave less cushion against reimbursement shocks or cyclical occupancy declines. Higher interest or refinancing needs could constrain capital allocation, making the balance sheet more sensitive to operational setbacks over the medium term.
Rising M&A Valuations & CapEx NeedsAcquisition-driven growth depends on disciplined pricing and successful integrations. Elevated purchase prices and sizable remediation or replacement capex for older facilities lengthen payback periods and can compress long-term returns if realized synergies or occupancy ramps are slower than modeled.
Regulatory & Labor Pressure On MarginsDependence on Medicare/Medicaid reimbursement and labor-intensive care exposes margins to policy shifts and wage pressure. Structural reimbursement reform or adverse state budget actions, combined with elevated labor costs, can persistently pressure operating margins and cash conversion.
The Ensign Group News
ENSG FAQ
What was The Ensign Group’s price range in the past 12 months?
The Ensign Group lowest stock price was $125.33 and its highest was $218.00 in the past 12 months.
What is The Ensign Group’s market cap?
The Ensign Group’s market cap is $11.10B.
When is The Ensign Group’s upcoming earnings report date?
The Ensign Group’s upcoming earnings report date is Jul 23, 2026 which is in 84 days.
How were The Ensign Group’s earnings last quarter?
Currently, no data Available
Is The Ensign Group overvalued?
According to Wall Street analysts The Ensign Group’s price is currently Undervalued.
Does The Ensign Group pay dividends?
The Ensign Group pays a Quarterly dividend of $0.063 which represents an annual dividend yield of 0.14%. See more information on The Ensign Group dividends here
What is The Ensign Group’s EPS estimate?
The Ensign Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does The Ensign Group have?
The Ensign Group has 58,413,970 shares outstanding.
What happened to The Ensign Group’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of The Ensign Group?
Currently, no hedge funds are holding shares in ENSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
The Ensign Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$222.33 (11.11% Upside)
$222.33 (11.11% Upside)
Blogger Sentiment
Bullish
ENSG Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 151.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 1.0%
Last 30 Days ▲ 1.5%
Last 30 Days ▲ 1.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
56.59%
12-Months-Change
Fundamentals
Return on Equity
16.58%
Trailing 12-Months
Asset Growth
16.69%
Trailing 12-Months
Company Description
The Ensign Group
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
ENSG Company Deck
ENSG Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicates a strongly positive performance profile: record quarterly and annual financial results, multi-year high growth rates, improving occupancy and skilled mix, robust liquidity and disciplined but active M&A and real estate expansion. Management acknowledges manageable headwinds — higher acquisition valuations, construction and CapEx needs, regulatory/reimbursement variability and remaining pockets of lower occupancy — but presents concrete operational progress (quality metrics, turnover reduction, specialty program wins) and ample capital to pursue opportunities. Overall, the positives — driven by double-digit revenue and earnings growth, strong cash flow, low leverage and demonstrated acquisition and transition capability — substantially outweigh the noted challenges.View all ENSG earnings summariesENSG Stock 12 Month Forecast
Average Price Target
$222.33
▲(11.11% Upside)
Technical Analysis
Encompass Health
―
National Healthcare
―
Tenet Healthcare
―
Universal Health
―
Surgery Partners
―
Ownership Overview
3.59% Insiders
33.81% Mutual Funds
5.86% Other Institutional Investors
33.96% Public Companies and
Individual Investors